The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Penile cancer: Importance of circumcision, human papillomavirus and smoking in in situ and invasive disease
Open accessAbstract
Few population‐based case‐control studies have assessed etiologic factors for penile cancer. Past infection with high‐risk human papillomavirus (HPV) is a known risk factor for penile cancer; however, few previous studies have related the HPV DNA status of the tumor to potential demographic and behavioral risk factors for the disease or evaluated whether in situ and invasive penile cancer share risk factors. Little information is available on the role and timing of circumcision in the etiology of penile cancer. We conducted a population‐based case‐control study in western Washington state that included 137 men diagnosed with in situ (n = 75) or invasive (n = 62) penile cancer between January 1, 1979, and December 31, 1998, and 671 control men identified through random digit dialing. Cases and controls were interviewed in person and provided peripheral blood samples. Case and control blood samples were tested for antibodies to HPV16 and HSV‐2, and tumor specimens from cases were tested for HPV DNA. Men not circumcised during childhood were at increased risk of invasive (OR = 2.3, 95% CI 1.3–4.1) but not in situ (OR = 1.1, 95% CI 0.6–1.8) penile cancer. Approximately 35% of men with penile cancer who had not been circumcised in childhood reported a history of phimosis compared to 7.6% of controls (OR = 7.4, 95% CI 3.7–15.0). Penile conditions such as tear, rash and injury were associated with increased risk of disease. Among men not circumcised in childhood, phimosis was strongly associated with development of invasive penile cancer (OR = 11.4, 95% CI 5.0–25.9). When we restricted our analysis to men who did not have phimosis, the risk of invasive penile cancer associated with not having been circumcised in childhood was not elevated (OR = 0.5, 95% CI 0.1–2.5). Cigarette smoking was associated with a 4.5‐fold risk (95% CI 2.0–10.1) of invasive penile cancer. HPV DNA was detected in 79.8% of tumor specimens, and 69.1% of tumors were HPV16‐positive. The proportion of HPV DNA‐positive tumors did not vary by any risk factors evaluated. Many risk factors were common for both in situ and invasive disease. However, 3 factors that did not increase the risk for in situ cancer proved significant risk factors for invasive penile cancer: lack of circumcision during childhood, phimosis and cigarette smoking. The high percentage of HPV DNA‐positive tumors in our study is consistent with a strong association between HPV infection and the development of penile cancer regardless of circumcision status. Circumcision in early childhood may help prevent penile cancer by eliminating phimosis, a significant risk factor for the disease. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
Castellsagué, X., Bosch, F. X., Muñoz, N., Meijer, C. J. L. M., Shah, K. V., de Sanjosé, S., Eluf-Neto, J., Ngelangel, C. A., Chichareon, S., Smith, J. S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011688 · Cited by 804
Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., & Galloway, D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315498 · Cited by 575
Self-citationHistory of Circumcision, Medical Conditions, and Sexual Activity and Risk of Penile Cancer
Maden, C., Sherman, K. J., Beckmann, A. M., Hislop, T. G., Teh, C.-Z., Ashley, R. L., & Daling, J. R. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.1.19 · Cited by 426
Self-citationDehan, E., & Pagano, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.014 · Cited by 352
Cigarette Smoking and the Risk of Anogenital Cancer
Daling, J. R., Sherman, K. J., Hislop, T. G., Maden, C., Mandelson, M. T., Beckmann, A. M., & Weiss, N. S. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116270 · Cited by 289
Self-citationEncyclopedia of Epidemiologic Methods
(2002) · Technometrics · doi:10.1198/tech.2002.s736 · Cited by 248
Gross, G., & Pfister, H. (2004) · Medical Microbiology and Immunology · doi:10.1007/s00430-003-0181-2 · Cited by 231
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter, J. J., Madeleine, M. M., Shera, K. A., Schwartz, S. M., Cushing‐Haugen, K. L., Wipf, G. C., Porter, P. L., Daling, J. R., McDougall, J. K., & Galloway, D. A. (2001) · PubMed · Cited by 182
Self-citationPenile cancer: is there an epidemiological role for smoking and sexual behaviour?
Hellberg, D., Valentin, J., Eklund, T. J., & Nilsson, S. (1987) · BMJ · doi:10.1136/bmj.295.6609.1306 · Cited by 155
Lungu, O., Wright, T. C., & Silverstein, S. J. (1992) · Molecular and Cellular Probes · doi:10.1016/0890-8508(92)90059-7 · Cited by 151
Risk factors for penile cancer: Results from a case‐control study in china
Brinton, L. A., Li, J., Rong, S.-D., Huang, S., Sheng, X. B., Bai‐Gao, S., Zhe‐Jun, Z., SCHIFFMAN, M. H., & Dawsey, S. M. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470406 · Cited by 96
Picconi, M. A., Eij�n, A. M., Dist�fano, A. L., Pueyo, S., Alonio, L. V., Gorostidy, S., Teyssi�, A. R., & Casab�, A. (2000) · Journal of Medical Virology · Cited by 91
Chan, K. W., Lam, A. K.-Y., Chan, A. C. L., Lau, P., & Srivastava, G. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.9.823 · Cited by 79
Telomerase activation in cervical cancer.
Anderson, S., Shera, K. A., Ihle, J., Billman, L., Goff, B. A., Greer, B. E., Tamimi, H. K., McDougall, J. K., & Klingelhutz, A. J. (1997) · Europe PMC (PubMed Central) · Cited by 67
Self-citationUse of densitometric analysis for interpreting HSV serologies based on Western blot
Ashley, R. L., & Militoni, J. (1987) · Journal of Virological Methods · doi:10.1016/0166-0934(87)90121-2 · Cited by 55
Random Digit Dialing Sampling for Case–Control Studies
Waksberg, J. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a03106 · Cited by 17
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study
Giuliano, A. R., Lee, J.-H., Fulp, W., Villa, L. L., Lazcano, E., Papenfuss, M. R., Abrahamsen, M., Salmeron, J., Anic, G. M., Rollison, D. E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62342-2 · Cited by 500
Systematic review of human papillomavirus prevalence in invasive penile cancer
Backes, D. M., Kurman, R. J., Pimenta, J. M., & Smith, J. S. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9276-9 · Cited by 420
Penile cancer: epidemiology, pathogenesis and prevention
Bleeker, M. C. G., Heideman, D. A. M., Snijders, P. J. F., Horenblas, S., Dillner, J., & Meijer, C. J. L. M. (2009) · World Journal of Urology · doi:10.1007/s00345-008-0302-z · Cited by 369
TASK FORCE ON CIRCUMCISION, Blank, S., Brady, M., Buerk, E., Carlo, W., Diekema, D., Freedman, A., Maxwell, L., & Wegner, S. (2012) · Pediatrics · doi:10.1542/peds.2012-1990 · Cited by 337
Metadata
- Authors
- Daling, J. R., Madeleine, M. M., Johnson, L. G., Schwartz, S. M., Shera, K. A., Wurscher, M. A., Carter, J. J., Porter, P. L., Galloway, D. A., McDougall, J. K., & Krieger, J. N.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2005-04-11
- Volume
- 116
- Issue
- 4
- Pages
- 606-616
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2013639959
- Cited by
- 446
- References
- 17
- FWCI
- 16.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.